Literature DB >> 20849530

Intramuscular AAV delivery of NT-3 alters synaptic transmission to motoneurons in adult rats.

Jeffrey C Petruska1, Brandon Kitay, Vanessa S Boyce, Brian K Kaspar, Damien D Pearse, Fred H Gage, Lorne M Mendell.   

Abstract

We examined whether elevating levels of neurotrophin-3 (NT-3) in the spinal cord and dorsal root ganglion (DRG) would alter connections made by muscle spindle afferent fibers on motoneurons. Adeno-associated virus (AAV) serotypes AAV1, AAV2 and AAV5, selected for their tropism profile, were engineered with the NT-3 gene and administered to the medial gastrocnemius muscle in adult rats. ELISA studies in muscle, DRG and spinal cord revealed that NT-3 concentration in all tissues peaked about 3 months after a single viral injection; after 6 months NT-3 concentration returned to normal values. Intracellular recording in triceps surae motoneurons revealed complex electrophysiological changes. Moderate elevation in cord NT-3 resulted in diminished segmental excitatory postsynaptic potential (EPSP) amplitude, perhaps as a result of the observed decrease in motoneuron input resistance. With further elevation in NT-3 expression, the decline in EPSP amplitude was reversed, indicating that NT-3 at higher concentration could increase EPSP amplitude. No correlation was observed between EPSP amplitude and NT-3 concentration in the DRG. Treatment with control viruses could elevate NT-3 levels minimally resulting in measurable electrophysiological effects, perhaps as a result of inflammation associated with injection. EPSPs elicited by stimulation of the ventrolateral funiculus underwent a consistent decline in amplitude independent of NT-3 level. These novel correlations between modified NT-3 expression and single-cell electrophysiological parameters indicate that intramuscular administration of AAV(NT-3) can exert long-lasting effects on synaptic transmission to motoneurons. This approach to neurotrophin delivery could be useful in modifying spinal function after injury.
© 2010 The Authors. European Journal of Neuroscience © 2010 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20849530      PMCID: PMC2943849          DOI: 10.1111/j.1460-9568.2010.07392.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  47 in total

1.  NT-3 evokes an LTP-like facilitation of AMPA/kainate receptor-mediated synaptic transmission in the neonatal rat spinal cord.

Authors:  V L Arvanov; B S Seebach; L M Mendell
Journal:  J Neurophysiol       Date:  2000-08       Impact factor: 2.714

2.  Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes.

Authors:  Zhijian Wu; Aravind Asokan; Joshua C Grieger; Lakshmanan Govindasamy; Mavis Agbandje-McKenna; R Jude Samulski
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

Review 3.  Adeno-associated virus serotypes: vector toolkit for human gene therapy.

Authors:  Zhijian Wu; Aravind Asokan; R Jude Samulski
Journal:  Mol Ther       Date:  2006-07-07       Impact factor: 11.454

4.  Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6.

Authors:  C Towne; B L Schneider; D Kieran; D E Redmond; P Aebischer
Journal:  Gene Ther       Date:  2009-09-03       Impact factor: 5.250

5.  Changes in truncated trkB and p75 receptor expression in the rat spinal cord following spinal cord hemisection and spinal cord hemisection plus neurotrophin treatment.

Authors:  V R King; E J Bradbury; S B McMahon; J V Priestley
Journal:  Exp Neurol       Date:  2000-10       Impact factor: 5.330

6.  Muscle injection of AAV-NT3 promotes anatomical reorganization of CST axons and improves behavioral outcome following SCI.

Authors:  Jenny Fortun; Raisa Puzis; Damien D Pearse; Fred H Gage; Mary Bartlett Bunge
Journal:  J Neurotrauma       Date:  2009-07       Impact factor: 5.269

7.  Neurotrophic factors promote and enhance locomotor recovery in untrained spinalized cats.

Authors:  Vanessa S Boyce; Maureen Tumolo; Itzhak Fischer; Marion Murray; Michel A Lemay
Journal:  J Neurophysiol       Date:  2007-07-25       Impact factor: 2.714

8.  Efficient retrograde neuronal transduction utilizing self-complementary AAV1.

Authors:  Edmund R Hollis; Ken Kadoya; Matthew Hirsch; Richard J Samulski; Mark H Tuszynski
Journal:  Mol Ther       Date:  2007-11-27       Impact factor: 11.454

9.  Functionally reduced sensorimotor connections form with normal specificity despite abnormal muscle spindle development: the role of spindle-derived neurotrophin 3.

Authors:  Neil A Shneider; George Z Mentis; Joshua Schustak; Michael J O'Donovan
Journal:  J Neurosci       Date:  2009-04-15       Impact factor: 6.167

Review 10.  The role of the adeno-associated virus capsid in gene transfer.

Authors:  Kim M Van Vliet; Veronique Blouin; Nicole Brument; Mavis Agbandje-McKenna; Richard O Snyder
Journal:  Methods Mol Biol       Date:  2008
View more
  24 in total

1.  Acute exercise prevents the development of neuropathic pain and the sprouting of non-peptidergic (GDNF- and artemin-responsive) c-fibers after spinal cord injury.

Authors:  Megan Ryan Detloff; Evan J Smith; Daniel Quiros Molina; Patrick D Ganzer; John D Houlé
Journal:  Exp Neurol       Date:  2014-02-19       Impact factor: 5.330

2.  Transplants of Neurotrophin-Producing Autologous Fibroblasts Promote Recovery of Treadmill Stepping in the Acute, Sub-Chronic, and Chronic Spinal Cat.

Authors:  Alexander J Krupka; Itzhak Fischer; Michel A Lemay
Journal:  J Neurotrauma       Date:  2016-12-20       Impact factor: 5.269

3.  Targeted tPA overexpression in denervated spinal motor neurons promotes stroke recovery in mice.

Authors:  Xinling Gan; Michael Chopp; Hongqi Xin; Fengjie Wang; William Golembieski; Mei Lu; Li He; Zhongwu Liu
Journal:  J Cereb Blood Flow Metab       Date:  2020-01-27       Impact factor: 6.200

4.  Exercise modulates microRNAs that affect the PTEN/mTOR pathway in rats after spinal cord injury.

Authors:  Gang Liu; Megan Ryan Detloff; Kassi N Miller; Lauren Santi; John D Houlé
Journal:  Exp Neurol       Date:  2011-11-19       Impact factor: 5.330

Review 5.  Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.

Authors:  Monica Nizzardo; Chiara Simone; Marianna Falcone; Giulietta Riboldi; Federica Rizzo; Francesca Magri; Nereo Bresolin; Giacomo P Comi; Stefania Corti
Journal:  Cell Mol Life Sci       Date:  2011-11-18       Impact factor: 9.261

6.  Treadmill training stimulates brain-derived neurotrophic factor mRNA expression in motor neurons of the lumbar spinal cord in spinally transected rats.

Authors:  M S Joseph; N J K Tillakaratne; R D de Leon
Journal:  Neuroscience       Date:  2012-08-21       Impact factor: 3.590

Review 7.  Translational Challenges of Rat Models of Upper Extremity Dysfunction After Spinal Cord Injury.

Authors:  Laura Krisa; Madeline Runyen; Megan Ryan Detloff
Journal:  Top Spinal Cord Inj Rehabil       Date:  2018

8.  Intramuscular Neurotrophin-3 normalizes low threshold spinal reflexes, reduces spasms and improves mobility after bilateral corticospinal tract injury in rats.

Authors:  Claudia Kathe; Thomas Haynes Hutson; Stephen Brendan McMahon; Lawrence David Falcon Moon
Journal:  Elife       Date:  2016-10-19       Impact factor: 8.140

9.  Differential effects of brain-derived neurotrophic factor and neurotrophin-3 on hindlimb function in paraplegic rats.

Authors:  Vanessa S Boyce; Jihye Park; Fred H Gage; Lorne M Mendell
Journal:  Eur J Neurosci       Date:  2011-12-30       Impact factor: 3.386

10.  The Transcriptional Response of Neurotrophins and Their Tyrosine Kinase Receptors in Lumbar Sensorimotor Circuits to Spinal Cord Contusion is Affected by Injury Severity and Survival Time.

Authors:  M Tyler Hougland; Benjamin J Harrison; David S K Magnuson; Eric C Rouchka; Jeffrey C Petruska
Journal:  Front Physiol       Date:  2013-01-09       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.